Self-reported cognitive decline in Japanese patients with breast cancer treated with endocrine therapy.

CONCLUSIONS: Patients treated with endocrine therapy for breast cancer experience intricately intertwined impairments in several domains of cognitive function. They have an increased risk of psychological disorders corresponding to the degree of subjective cognitive function. PMID: 32114664 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32114664?dopt=Abstract

Source: Breast Cancer - February 28, 2020 Category: Cancer & Oncology Authors: Yamamoto S, Masutani E, Arao H Tags: Breast Cancer Source Type: research